Measles and mumps combined vaccine，live attenuated (Shanghai Institute of Biological Products)

麻疹腮腺炎联合减毒活疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles and mumps combined vaccine，live attenuated (Shanghai Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Combination vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMumpsMeasles

Global Approved IndicationsMumpsMeasles

Approved Indications in ChinaMumpsMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date2000/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesShanghai Institute of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsMumpsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD51